BIO logo

Bio-Rad Laboratories, Inc. (BIO) Cash from investing

annual CFI:

-$160.20M-$180.41M(-892.76%)
December 31, 2024

Summary

  • As of today (September 14, 2025), BIO annual cash flow from investing activities is -$160.20 million, with the most recent change of -$180.41 million (-892.76%) on December 31, 2024.
  • During the last 3 years, BIO annual CFI has risen by +$637.18 million (+79.91%).
  • BIO annual CFI is now -892.76% below its all-time high of $20.21 million, reached on December 31, 2023.

Performance

BIO Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

quarterly CFI:

-$115.40M-$118.30M(-4079.31%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BIO quarterly cash flow from investing activities is -$115.40 million, with the most recent change of -$118.30 million (-4079.31%) on June 30, 2025.
  • Over the past year, BIO quarterly CFI has dropped by -$84.47 million (-273.14%).
  • BIO quarterly CFI is now -164.12% below its all-time high of $179.99 million, reached on September 30, 2013.

Performance

BIO quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

TTM CFI:

-$198.68M-$84.47M(-73.96%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BIO TTM cash flow from investing activities is -$198.68 million, with the most recent change of -$84.47 million (-73.96%) on June 30, 2025.
  • Over the past year, BIO TTM CFI has dropped by -$187.36 million (-1654.66%).
  • BIO TTM CFI is now -379.84% below its all-time high of $71.00 million, reached on March 31, 2014.

Performance

BIO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BIO Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-892.8%-273.1%-1654.7%
3 y3 years+79.9%+20.1%+88.4%
5 y5 years+23.3%-30.3%+27.0%

BIO Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-892.8%+86.7%-259.8%+20.1%-517.5%+88.4%
5 y5-year-892.8%+86.7%-227.0%+87.4%-517.5%+88.4%
alltimeall time-892.8%+86.7%-164.1%+87.4%-379.8%+88.4%

BIO Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$115.40M(-4079.3%)
-$198.68M(+74.0%)
Mar 2025
-
$2.90M(-109.5%)
-$114.21M(-28.7%)
Dec 2024
-$160.20M(-892.8%)
-$30.54M(-45.1%)
-$160.20M(+178.8%)
Sep 2024
-
-$55.64M(+79.9%)
-$57.46M(+407.5%)
Jun 2024
-
-$30.93M(-28.2%)
-$11.32M(-123.8%)
Mar 2024
-
-$43.09M(-159.7%)
$47.59M(+135.5%)
Dec 2023
$20.21M(-101.7%)
$72.20M(-860.0%)
$20.21M(-118.3%)
Sep 2023
-
-$9.50M(-133.9%)
-$110.54M(-41.7%)
Jun 2023
-
$27.98M(-139.7%)
-$189.46M(-47.7%)
Mar 2023
-
-$70.47M(+20.4%)
-$361.93M(-70.0%)
Dec 2022
-$1.21B(+51.4%)
-$58.55M(-33.8%)
-$1.21B(-29.6%)
Sep 2022
-
-$88.42M(-38.8%)
-$1.72B(+0.4%)
Jun 2022
-
-$144.48M(-84.2%)
-$1.71B(+2.7%)
Mar 2022
-
-$916.14M(+61.5%)
-$1.67B(+108.8%)
Dec 2021
-$797.38M(+1223.5%)
-$567.43M(+597.5%)
-$797.38M(+184.7%)
Sep 2021
-
-$81.35M(-18.9%)
-$280.06M(+159.7%)
Jun 2021
-
-$100.28M(+107.5%)
-$107.86M(+12.2%)
Mar 2021
-
-$48.33M(-3.6%)
-$96.16M(+59.6%)
Dec 2020
-$60.25M(-71.2%)
-$50.11M(-155.2%)
-$60.25M(-15.5%)
Sep 2020
-
$90.85M(-202.6%)
-$71.34M(-73.8%)
Jun 2020
-
-$88.57M(+613.0%)
-$272.10M(+37.0%)
Mar 2020
-
-$12.42M(-79.7%)
-$198.60M(-4.9%)
Dec 2019
-$208.89M(+11.7%)
-$61.20M(-44.3%)
-$208.89M(+3.2%)
Sep 2019
-
-$109.91M(+629.3%)
-$202.50M(+65.8%)
Jun 2019
-
-$15.07M(-33.6%)
-$122.10M(-36.0%)
Mar 2019
-
-$22.71M(-58.6%)
-$190.88M(+2.1%)
Dec 2018
-$186.98M(+6.5%)
-$54.81M(+85.7%)
-$186.98M(+28.7%)
Sep 2018
-
-$29.51M(-64.8%)
-$145.25M(+11.3%)
Jun 2018
-
-$83.84M(+345.6%)
-$130.56M(+55.4%)
Mar 2018
-
-$18.82M(+43.8%)
-$84.00M(-52.2%)
Dec 2017
-$175.57M(-17.9%)
-$13.08M(-11.7%)
-$175.57M(-17.3%)
Sep 2017
-
-$14.81M(-60.3%)
-$212.26M(-15.4%)
Jun 2017
-
-$37.28M(-66.2%)
-$250.88M(-8.1%)
Mar 2017
-
-$110.39M(+121.8%)
-$273.06M(+27.9%)
Dec 2016
-$213.88M(+31.5%)
-$49.77M(-6.8%)
-$213.53M(-12.2%)
Sep 2016
-
-$53.43M(-10.2%)
-$243.32M(+12.1%)
Jun 2016
-
-$59.47M(+16.9%)
-$217.13M(+17.0%)
Mar 2016
-
-$50.86M(-36.1%)
-$185.53M(+14.1%)
Dec 2015
-$162.66M(-14.6%)
-$79.57M(+192.2%)
-$162.66M(+22.7%)
Sep 2015
-
-$27.23M(-2.3%)
-$132.53M(-8.2%)
Jun 2015
-
-$27.86M(-0.5%)
-$144.43M(-19.6%)
Mar 2015
-
-$27.99M(-43.4%)
-$179.58M(-5.7%)
Dec 2014
-$190.51M(+3414.3%)
-$49.44M(+26.4%)
-$190.51M(+3.9%)
Sep 2014
-
-$39.13M(-37.9%)
-$183.40M(-613.5%)
Jun 2014
-
-$63.02M(+61.9%)
$35.72M(-49.7%)
Mar 2014
-
-$38.92M(-8.1%)
$71.00M(-1409.7%)
Dec 2013
-$5.42M(-98.7%)
-$42.34M(-123.5%)
-$5.42M(-84.6%)
Sep 2013
-
$179.99M(-749.0%)
-$35.13M(-89.0%)
Jun 2013
-
-$27.73M(-76.0%)
-$319.04M(-27.8%)
Mar 2013
-
-$115.34M(+60.1%)
-$441.86M(+7.0%)
Dec 2012
-$412.80M(+7.7%)
-$72.04M(-30.7%)
-$412.80M(-19.1%)
Sep 2012
-
-$103.93M(-31.0%)
-$510.29M(+10.4%)
Jun 2012
-
-$150.55M(+74.5%)
-$462.18M(+17.8%)
Mar 2012
-
-$86.28M(-49.1%)
-$392.40M(+2.3%)
Dec 2011
-$383.41M(+77.1%)
-$169.52M(+203.7%)
-$383.41M(+44.1%)
Sep 2011
-
-$55.81M(-30.9%)
-$265.99M(-2.0%)
Jun 2011
-
-$80.78M(+4.5%)
-$271.44M(+25.2%)
Mar 2011
-
-$77.29M(+48.3%)
-$216.79M(+0.1%)
Dec 2010
-$216.51M(+23.1%)
-$52.10M(-15.0%)
-$216.51M(+15.8%)
Sep 2010
-
-$61.26M(+134.4%)
-$187.00M(-10.2%)
Jun 2010
-
-$26.14M(-66.1%)
-$208.33M(-13.3%)
Mar 2010
-
-$77.01M(+240.9%)
-$240.25M(+36.5%)
Dec 2009
-$175.95M(+20.4%)
-$22.59M(-72.6%)
-$175.95M(-19.1%)
Sep 2009
-
-$82.59M(+42.3%)
-$217.60M(+32.1%)
Jun 2009
-
-$58.05M(+356.5%)
-$164.72M(+33.0%)
Mar 2009
-
-$12.72M(-80.2%)
-$123.86M(-15.2%)
Dec 2008
-$146.11M(-42.6%)
-$64.24M(+116.2%)
-$146.11M(-69.3%)
Sep 2008
-
-$29.71M(+72.9%)
-$476.36M(+76.0%)
Jun 2008
-
-$17.19M(-50.8%)
-$270.60M(-10.2%)
Mar 2008
-
-$34.96M(-91.1%)
-$301.25M(+18.4%)
Dec 2007
-$254.43M(+22.5%)
-$394.49M(-324.1%)
-$254.43M(-483.2%)
Sep 2007
-
$176.04M(-468.0%)
$66.40M(-138.6%)
Jun 2007
-
-$47.84M(-503.4%)
-$171.93M(-15.8%)
Mar 2007
-
$11.86M(-116.1%)
-$204.08M(-1.7%)
Dec 2006
-$207.70M
-$73.66M(+18.3%)
-$207.70M(+64.9%)
Sep 2006
-
-$62.29M(-22.1%)
-$125.92M(+24.8%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$79.99M(-1071.1%)
-$100.92M(+9.9%)
Mar 2006
-
$8.24M(+1.4%)
-$91.82M(+1387.7%)
Dec 2005
-$6.17M(-96.7%)
$8.12M(-121.8%)
-$6.17M(-94.4%)
Sep 2005
-
-$37.29M(-47.4%)
-$110.78M(-6.0%)
Jun 2005
-
-$70.89M(-175.5%)
-$117.89M(+104.1%)
Mar 2005
-
$93.89M(-197.3%)
-$57.76M(-69.0%)
Dec 2004
-$186.32M(+74.1%)
-$96.49M(+117.3%)
-$186.32M(+56.8%)
Sep 2004
-
-$44.39M(+312.4%)
-$118.81M(+5.9%)
Jun 2004
-
-$10.77M(-68.9%)
-$112.15M(-7.3%)
Mar 2004
-
-$34.67M(+19.6%)
-$120.94M(+13.0%)
Dec 2003
-$106.99M(+96.3%)
-$28.98M(-23.2%)
-$106.99M(+17.9%)
Sep 2003
-
-$37.73M(+93.0%)
-$90.74M(+37.5%)
Jun 2003
-
-$19.55M(-5.7%)
-$65.98M(-1.0%)
Mar 2003
-
-$20.73M(+62.9%)
-$66.64M(+22.3%)
Dec 2002
-$54.50M(+14.7%)
-$12.73M(-1.9%)
-$54.50M(+2.9%)
Sep 2002
-
-$12.97M(-35.8%)
-$52.95M(-8.6%)
Jun 2002
-
-$20.21M(+135.5%)
-$57.92M(+20.9%)
Mar 2002
-
-$8.58M(-23.2%)
-$47.92M(+0.9%)
Dec 2001
-$47.50M(-611.0%)
-$11.18M(-37.7%)
-$47.50M(+31.5%)
Sep 2001
-
-$17.94M(+75.6%)
-$36.13M(-937.9%)
Jun 2001
-
-$10.22M(+25.2%)
$4.31M(-38.6%)
Mar 2001
-
-$8.16M(-4440.4%)
$7.02M(-24.5%)
Dec 2000
$9.30M(-104.2%)
$188.00K(-99.2%)
$9.30M(-104.6%)
Sep 2000
-
$22.50M(-399.6%)
-$202.07M(-11.2%)
Jun 2000
-
-$7.51M(+27.6%)
-$227.61M(+0.7%)
Mar 2000
-
-$5.88M(-97.2%)
-$225.99M(+1.2%)
Dec 1999
-$223.32M(+784.3%)
-$211.18M(+6835.2%)
-$223.32M(+1083.4%)
Sep 1999
-
-$3.04M(-48.3%)
-$18.87M(+0.4%)
Jun 1999
-
-$5.88M(+83.2%)
-$18.79M(-17.8%)
Mar 1999
-
-$3.21M(-52.3%)
-$22.85M(-9.5%)
Dec 1998
-$25.25M(-54.8%)
-$6.73M(+126.9%)
-$25.25M(-55.3%)
Sep 1998
-
-$2.97M(-70.2%)
-$56.51M(-10.5%)
Jun 1998
-
-$9.94M(+77.0%)
-$63.17M(+9.9%)
Mar 1998
-
-$5.62M(-85.2%)
-$57.46M(+2.7%)
Dec 1997
-$55.92M(+276.8%)
-$37.98M(+294.5%)
-$55.92M(+130.3%)
Sep 1997
-
-$9.63M(+127.3%)
-$24.28M(+33.0%)
Jun 1997
-
-$4.24M(+3.8%)
-$18.25M(+6.6%)
Mar 1997
-
-$4.08M(-35.6%)
-$17.12M(+15.4%)
Dec 1996
-$14.84M(+6.7%)
-$6.34M(+76.1%)
-$14.84M(+23.6%)
Sep 1996
-
-$3.60M(+16.1%)
-$12.00M(+17.6%)
Jun 1996
-
-$3.10M(+72.2%)
-$10.20M(-19.0%)
Mar 1996
-
-$1.80M(-48.6%)
-$12.60M(-9.4%)
Dec 1995
-$13.91M(+6.6%)
-$3.50M(+94.4%)
-$13.90M(-4.1%)
Sep 1995
-
-$1.80M(-67.3%)
-$14.50M(-10.5%)
Jun 1995
-
-$5.50M(+77.4%)
-$16.20M(+14.1%)
Mar 1995
-
-$3.10M(-24.4%)
-$14.20M(+8.4%)
Dec 1994
-$13.06M(+49.0%)
-$4.10M(+17.1%)
-$13.10M(+15.9%)
Sep 1994
-
-$3.50M(0.0%)
-$11.30M(+34.5%)
Jun 1994
-
-$3.50M(+75.0%)
-$8.40M(-28.2%)
Mar 1994
-
-$2.00M(-13.0%)
-$11.70M(+33.0%)
Dec 1993
-$8.76M(-27.4%)
-$2.30M(+283.3%)
-$8.80M(+23.9%)
Sep 1993
-
-$600.00K(-91.2%)
-$7.10M(-19.3%)
Jun 1993
-
-$6.80M(-855.6%)
-$8.80M(-3.3%)
Mar 1993
-
$900.00K(-250.0%)
-$9.10M(-24.8%)
Dec 1992
-$12.07M(-54.7%)
-$600.00K(-73.9%)
-$12.10M(-31.3%)
Sep 1992
-
-$2.30M(-67.6%)
-$17.60M(-26.4%)
Jun 1992
-
-$7.10M(+238.1%)
-$23.90M(+2.1%)
Mar 1992
-
-$2.10M(-65.6%)
-$23.40M(-12.0%)
Dec 1991
-$26.62M(+51.4%)
-$6.10M(-29.1%)
-$26.60M(-2.9%)
Sep 1991
-
-$8.60M(+30.3%)
-$27.40M(+20.2%)
Jun 1991
-
-$6.60M(+24.5%)
-$22.80M(+16.3%)
Mar 1991
-
-$5.30M(-23.2%)
-$19.60M(+11.4%)
Dec 1990
-$17.58M(-5.6%)
-$6.90M(+72.5%)
-$17.60M(+64.5%)
Sep 1990
-
-$4.00M(+17.6%)
-$10.70M(+59.7%)
Jun 1990
-
-$3.40M(+3.0%)
-$6.70M(+103.0%)
Mar 1990
-
-$3.30M
-$3.30M
Dec 1989
-$18.61M(+102.9%)
-
-
Dec 1988
-$9.18M(-35.6%)
-
-
Dec 1987
-$14.24M(-38.8%)
-
-
Dec 1986
-$23.27M(+525.7%)
-
-
Dec 1985
-$3.72M(+6.0%)
-
-
Dec 1984
-$3.51M(-63.3%)
-
-
Dec 1983
-$9.55M(<-9900.0%)
-
-
Dec 1982
$40.00K(-100.9%)
-
-
Dec 1981
-$4.32M(-51.2%)
-
-
Dec 1980
-$8.84M
-
-

FAQ

  • What is Bio-Rad Laboratories, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. annual CFI year-on-year change?
  • What is Bio-Rad Laboratories, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. quarterly CFI year-on-year change?
  • What is Bio-Rad Laboratories, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. TTM CFI year-on-year change?

What is Bio-Rad Laboratories, Inc. annual cash flow from investing activities?

The current annual CFI of BIO is -$160.20M

What is the all time high annual CFI for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high annual cash flow from investing activities is $20.21M

What is Bio-Rad Laboratories, Inc. annual CFI year-on-year change?

Over the past year, BIO annual cash flow from investing activities has changed by -$180.41M (-892.76%)

What is Bio-Rad Laboratories, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of BIO is -$115.40M

What is the all time high quarterly CFI for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high quarterly cash flow from investing activities is $179.99M

What is Bio-Rad Laboratories, Inc. quarterly CFI year-on-year change?

Over the past year, BIO quarterly cash flow from investing activities has changed by -$84.47M (-273.14%)

What is Bio-Rad Laboratories, Inc. TTM cash flow from investing activities?

The current TTM CFI of BIO is -$198.68M

What is the all time high TTM CFI for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high TTM cash flow from investing activities is $71.00M

What is Bio-Rad Laboratories, Inc. TTM CFI year-on-year change?

Over the past year, BIO TTM cash flow from investing activities has changed by -$187.36M (-1654.66%)
On this page